Actively Recruiting
Study of Huaier Granule as Additional Treatment After Surgery for High-risk Early-stage Triple-negative Breast Cancer
Led by Fudan University · Updated on 2024-06-27
1072
Participants Needed
34
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of Huaier Granule as a postoperative adjuvant therapy for high-risk early-stage triple-negative invasive ductal carcinoma, a type of aggressive breast cancer known for higher recurrence rates and poorer prognosis. This prospective, multicenter, randomized, parallel controlled, open-label study aims to assess whether adding Huaier Granule improves disease-free survival and quality of life compared to conventional treatment alone. Participants are randomly assigned to one of two groups the experimental group receives Huaier Granule orally at 20 grams three times daily alongside conventional postoperative treatment, while the control group receives only conventional treatment. The Huaier Granule treatment starts from the beginning of adjuvant therapy and can continue up to two years or until disease progression, intolerable side effects, withdrawal, or death. Follow-up includes regular visits every three months during the first two years of treatment and every six months during the subsequent three-year survival follow-up. During the study, participants undergo scheduled assessments to monitor disease-free survival rates, overall survival, quality of life changes, and any adverse events or drug reactions. The primary outcome is the 3-year disease-free survival rate, with secondary outcomes including 5-year survival rates and quality of life evaluations. Safety monitoring continues for three years after enrollment, and participants remain under observation for a total of five years to evaluate long-term effects and outcomes.
CONDITIONS
Brief Title
Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Research Team
Z
Zhimin Shao, PhD
L
Liang Huang, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here